What is the primary objective of ISO 45001?

ISO 45001 specifies requirements for an occupational health and safety management system (OHSMS) to enable organizations to provide safe and healthy workplaces by preventing work-related injury and ill health, and proactively improving OH&S performance. It follows the Plan-Do-Check-Act (PDCA) cycle across Clauses 4–10, embedding OH&S into business processes through context analysis, leadership accountability, risk-based planning, operational controls, performance evaluation, and continual improvement.

Who is legally or professionally required to comply with ISO 45001?

No organizations are legally required to comply with ISO 45001, as it is a voluntary international standard applicable to any size or sector. It is professionally adopted by high-risk industries like manufacturing, construction, oil & gas, and healthcare to demonstrate due diligence, meet supply-chain expectations, reduce incidents, and integrate with management systems. Scalability suits SMEs to multinationals.

Does ISO 45001 require an external audit or third-party certification?

ISO 45001 does not require external audits or third-party certification; these are voluntary. Organizations must conduct internal audits (Clause 9.2) and management reviews (Clause 9.3) to evaluate OHSMS effectiveness. Certification by accredited bodies involves Stage 1 (documentation) and Stage 2 (effectiveness) audits, followed by annual surveillance and triennial recertification.

How often should an assessment for ISO 45001 be performed?

ISO 45001 requires organizations to determine the frequency of performance evaluations, including monitoring, measurement, internal audits, and management reviews, based on risks, processes, and context. Clause 9 mandates regular internal audits (typically annually, risk-based) and management reviews (at least annually), with continual monitoring of KPIs like leading/lagging indicators to ensure OHSMS suitability, adequacy, and effectiveness.

What are the consequences of non-compliance with ISO 45001?

Non-compliance with ISO 45001 carries no direct penalties, as it is voluntary, but exposes organizations to regulatory fines, litigation, insurance premium hikes, and reputational damage from unmanaged OH&S risks. Poor OHSMS performance leads to incidents, operational disruptions, lost contracts, and failure to meet legal obligations identified in Clause 6.1, undermining continual improvement (Clause 10).

Can ISO 45001 be mapped to other international frameworks?

Yes, ISO 45001 uses the High-Level Structure (Annex SL) to facilitate mapping and integration with other ISO management system standards. Common elements like Clauses 4–10 (context, leadership, planning, support, operation, evaluation, improvement) enable unified processes for documented information (7.5), audits (9.2), and reviews (9.3), reducing duplication in integrated management systems.

What is the first step to begin implementing ISO 45001?

The first step to implement ISO 45001 is securing top management commitment and conducting a gap analysis of the organization's context (Clause 4). This involves understanding internal/external issues, interested parties' needs (4.2), defining OHSMS scope (4.3), and assessing current practices against Clauses 4–10 to produce a prioritized roadmap.

What is the primary objective of FDA 21 CFR Part 11?

FDA 21 CFR Part 11 establishes criteria under which the agency considers electronic records and electronic signatures trustworthy, reliable, and equivalent to paper records and handwritten signatures (§11.1(a)). This equivalency enables electronic methods while ensuring authenticity, integrity, confidentiality (when appropriate), and non-repudiation through controls like validation (§11.10(a)), audit trails (§11.10(e)), access limitations (§11.10(d)), and signature linking (§11.70).

Who is legally or professionally required to comply with FDA 21 CFR Part 11?

Organizations using electronic records or signatures in lieu of paper for predicate rule-required records, or relying on them for regulated activities, must comply with FDA 21 CFR Part 11 (§11.1(b)). This includes pharmaceutical, biotech, medical device firms, and CROs/CMOs maintaining records under GMP (21 CFR 211), GLP (Part 58), or QSR (Part 820); applies to closed (§11.10) or open systems (§11.30); excludes paper records transmitted electronically.

Does FDA 21 CFR Part 11 require an external audit or third-party certification?

No, FDA 21 CFR Part 11 does not require external audits or third-party certification. Compliance is demonstrated through internal controls, validation (§11.10(a)), SOPs, training (§11.10(i)), and inspection readiness (§11.1(e)), with systems and documentation available for FDA review; 2003 guidance exercises discretion on some elements but enforces predicate rules.

How often should an assessment for FDA 21 CFR Part 11 be performed?

FDA 21 CFR Part 11 does not specify a fixed frequency for assessments; they must occur via change control, periodic reviews, and risk-based validation lifecycle. Ongoing evaluation aligns with operational checks (§11.10(f)), documentation controls (§11.10(k)), and predicate rules, triggered by system changes, inspections, or risk reassessments per 2003 guidance.

What are the consequences of non-compliance with FDA 21 CFR Part 11?

Non-compliance with FDA 21 CFR Part 11 results in FDA enforcement actions including Form 483 observations, warning letters, product holds, and predicate rule violations. Impacts include batch rejection, recalls, fines, and injunctions; enforced controls like access (§11.10(d)) and signatures (§11.100) failures lead to data integrity citations during inspections (§11.1(e)).

Can FDA 21 CFR Part 11 be mapped to other international frameworks?

FDA 21 CFR Part 11 cannot be directly mapped to other frameworks in this FAQ, as it must stand alone. Focus remains on its specific controls for electronic records/signatures under U.S. predicate rules, with narrow scope per 2003 guidance.

What is the first step to begin implementing FDA 21 CFR Part 11?

The first step to implement FDA 21 CFR Part 11 is to establish a formal applicability framework mapping predicate rules to records and assessing business reliance on electronic versions. Document scope decisions in SOPs (§11.1(b)), classify systems as closed/open (§11.3), and prioritize enforced controls like access and signatures per 2003 guidance.

Standards Comparison

ISO 45001 vs FDA 21 CFR Part 11

ISO 45001

Voluntary

2018

International standard for occupational health and safety management systems

FDA 21 CFR Part 11

Mandatory

1997

FDA regulation for trustworthy electronic records and signatures

Quick Verdict

ISO 45001 provides a voluntary global framework for occupational health and safety management, enabling certification and continual improvement. FDA 21 CFR Part 11 mandates controls for electronic records and signatures in life sciences, ensuring data integrity for regulatory compliance.

Occupational Health & Safety

ISO 45001

ISO 45001:2018 Occupational Health and Safety Management Systems

Cost

€€€

Complexity

High

Implementation Time

6-12 months

Key Features

Top management leadership accountability and commitment
Mandatory worker consultation and participation
Hierarchy of controls for hazard elimination
Annex SL structure for IMS integration
Risk and opportunities proactive management

Electronic Records

FDA 21 CFR Part 11

21 CFR Part 11: Electronic Records; Electronic Signatures

Cost

€€€€

Complexity

High

Implementation Time

12-18 months

Key Features

Risk-based validation ensuring system accuracy and integrity
Secure, time-stamped audit trails for all actions
Unique electronic signatures with non-repudiation controls
Access, authority, and device checks enforced
Closed/open system controls with encryption standards

Detailed Analysis

A comprehensive look at the specific requirements, scope, and impact of each standard.

ISO 45001 Details

What It Is

ISO 45001:2018 is an international certification standard for Occupational Health and Safety Management Systems (OHSMS). It provides a framework to prevent work-related injuries and ill health, improve OH&S performance, using a risk-based approach aligned with Annex SL (HLS) for integration with other ISO standards like ISO 9001 and 14001.

Key Components

Clauses 4-10 covering context, leadership, planning, support, operation, evaluation, improvement.
Emphasizes hierarchy of controls, worker participation, leadership accountability.
Built on PDCA cycle; no fixed controls but outcome-focused requirements.
Optional third-party certification via audits.

Why Organizations Use It

Reduces incidents, legal risks, insurance costs.
Enhances resilience, reputation, talent retention.
Meets stakeholder, supply-chain demands.
Drives continual improvement, competitive edge.

Implementation Overview

Phased: gap analysis, policy/objectives, controls, audits.
Scalable for all sizes/sectors; 6-12 months typical.
Involves training, documented info, management reviews.

FDA 21 CFR Part 11 Details

What It Is

FDA 21 CFR Part 11 is a U.S. FDA regulation setting criteria under which electronic records and electronic signatures are trustworthy, reliable, and equivalent to paper records and handwritten signatures. It targets FDA-regulated records created, modified, or maintained electronically under predicate rules. Employs a risk-based approach, narrowed by 2003 FDA guidance with enforcement discretion on validation, audit trails, retention.

Key Components

**Subpart AScope, implementation, definitions (closed/open systems).
**Subpart BClosed (§11.10: validation, audit trails, access, checks) and open (§11.30: encryption, digital signatures) system controls; signature linking.
**Subpart CSignature uniqueness (§11.100), components (§11.200), ID/password controls (§11.300). Built on authenticity, integrity, non-repudiation; no certification, compliance via inspection.

Why Organizations Use It

Enables paperless operations in pharma, biotech, devices; avoids enforcement (warnings, holds); ensures data integrity for investigations/CAPA; boosts efficiency, inspection readiness; builds regulator/partner trust.

Implementation Overview

Phased: scope predicate records, risk assess/classify systems, validate (URS, IQ/OQ/PQ), deploy controls/training, change control. For medium-large FDA-regulated firms; ongoing audits, no external cert.

Key Differences

Aspect	ISO 45001	FDA 21 CFR Part 11
Scope	OH&S management systems, PDCA cycle, Clauses 4-10	Electronic records/signatures trustworthiness, system controls
Industry	All sectors worldwide, scalable to any size	FDA-regulated life sciences, pharma, devices, US-focused
Nature	Voluntary international certification standard	Mandatory US federal regulation with enforcement
Testing	Internal audits, management reviews, certification audits	Risk-based system validation, IQ/OQ/PQ, FDA inspections
Penalties	Loss of certification, no legal fines	Warning letters, fines, product holds, enforcement actions

Scope

ISO 45001

OH&S management systems, PDCA cycle, Clauses 4-10

FDA 21 CFR Part 11

Electronic records/signatures trustworthiness, system controls

Industry

ISO 45001

All sectors worldwide, scalable to any size

FDA 21 CFR Part 11

FDA-regulated life sciences, pharma, devices, US-focused

Nature

ISO 45001

Voluntary international certification standard

FDA 21 CFR Part 11

Mandatory US federal regulation with enforcement

Testing

ISO 45001

Internal audits, management reviews, certification audits

FDA 21 CFR Part 11

Risk-based system validation, IQ/OQ/PQ, FDA inspections

Penalties

ISO 45001

Loss of certification, no legal fines

FDA 21 CFR Part 11

Warning letters, fines, product holds, enforcement actions

Frequently Asked Questions

Common questions about ISO 45001 and FDA 21 CFR Part 11

ISO 45001 FAQ

FDA 21 CFR Part 11 FAQ

You Might also be Interested in These Articles...

From Reactive Gatekeeper to Proactive Strategist: How Compliance Software Reshapes the Compliance Professional's Day

Discover how compliance software automates monitoring, delivers real-time insights, and transforms compliance pros from reactive gatekeepers to proactive strate

From SOC to AI-Native CDC: Redefining Triage and Response in 2026

Explore the shift from SOCs to AI-Native CDCs. Autonomous agents handle Tier 1 triage in 2026, empowering analysts for complex threats. Discover the future of c

Real-World ISO 27701 Success: Synthesized Case Studies, Metrics, and Lessons for Privacy Resilience

Real-world ISO 27701 success from Tribeca, Kocho: DSAR efficiency gains, risk score reductions, certification ROI. Synthesized metrics prove privacy resilience

Run Maturity Assessments with GRADUM

Transform your compliance journey with our AI-powered assessment platform

Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

100+ Standards & Regulations

AI-Powered Insights

Collaborative Assessments

Actionable Recommendations

Explore More Comparisons

See how ISO 45001 and FDA 21 CFR Part 11 compare against other standards

Other ISO 45001 Comparisons

Other FDA 21 CFR Part 11 Comparisons

What It Is

Key Components

Clauses 4-10 covering context, leadership, planning, support, operation, evaluation, improvement.

Emphasizes hierarchy of controls, worker participation, leadership accountability.

Built on PDCA cycle; no fixed controls but outcome-focused requirements.

Optional third-party certification via audits.

What It Is

Key Components

**Subpart AScope, implementation, definitions (closed/open systems).

**Subpart BClosed (§11.10: validation, audit trails, access, checks) and open (§11.30: encryption, digital signatures) system controls; signature linking.

**Subpart CSignature uniqueness (§11.100), components (§11.200), ID/password controls (§11.300). Built on authenticity, integrity, non-repudiation; no certification, compliance via inspection.

Aspect

ISO 45001

FDA 21 CFR Part 11

Scope

OH&S management systems, PDCA cycle, Clauses 4-10

Electronic records/signatures trustworthiness, system controls

Industry

All sectors worldwide, scalable to any size

FDA-regulated life sciences, pharma, devices, US-focused

Nature

Voluntary international certification standard

Mandatory US federal regulation with enforcement

Testing

Internal audits, management reviews, certification audits

Risk-based system validation, IQ/OQ/PQ, FDA inspections

Penalties

Loss of certification, no legal fines

Warning letters, fines, product holds, enforcement actions